A Clinical Study Exploring CT1190B in the Treatment of Patients with Relapsed/refractory B-cell Non-Hodgkin Lymphoma

NCT06734871 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

B-Cell Non-Hodgkin Lymphoma

Interventions

DRUG: CAR T cells

Sponsor

Aibin Liang，MD，Ph.D.